I definitely attacked the data. The lump in all sorts of RCTs that really meaningful (don't measure against standard of care). There are negative studies where they fish out alternative endpoints and only report those.
See here:
https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3714649^This doesn't seem to be included even thought it reports a complete miss of primary endpoint (had to go fishing for subgroups to find a signal).
Nearly all the positive studies state the need for additional large scale trials. They are being run.
We will know the answer. Until then, it is irresponsible to go around claiming it's a miracle drug.
The phase 3 study for the Pfizer mRNA vaccine was published in NJEM. There has been peer review. More than 8 people got the disease across both arms. I have no clue what you're talking about?
The vaccine trials (Moderna and Pfizer) were based on symptomatic cases confirmed with tests. This is in the literature.
So yes, thank you for highlighting the differences:
1) Vaccine trial used large, randomized trials against the standard of care (in this case placebo).
2) Vaccine trials reported a single primary endpoint
If you are still convinced by HCQ you are of course going to be convinced by a few small, poorly run studies.
A general rule is that lots of bad studies bundled together doesn't suddenly make a good one. Garbage in, garbage out.
It's telling that you somehow think a 50k person top-of-the-line clinical trial is worse than several 10-100 person trails using different controls, dosing, end points, etc.
If you are a believer in evidence based medicine you should be 100% on board with the vaccine and skeptical but optimistic for IVM.
Again, dogma seems to rule.